Clinical Trial Update: Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the safety and potential efficacy of Angiotensin-(1-7) in individuals with moderate to severe traumatic brain injury, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Drugs mentioned

• Angiotensin-(1-7) (Angiotensin-(1-7))

Snippet

Sponsor: University of Arizona | Conditions: Traumatic Brain Injury | Phase 1, Phase 2 | Status: RECRUITING